DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,197,461 | +8.2% | 8,857 | +4.7% | 0.08% | +12.3% |
| Q2 2023 | $2,030,468 | -10.4% | 8,460 | -5.9% | 0.07% | -2.7% |
| Q1 2023 | $2,265,076 | -1.0% | 8,986 | +4.2% | 0.08% | -8.5% |
| Q4 2022 | $2,288,200 | +12.5% | 8,621 | +9.5% | 0.08% | +5.1% |
| Q3 2022 | $2,034,000 | -6.3% | 7,875 | -8.0% | 0.08% | +4.0% |
| Q2 2022 | $2,170,000 | -12.3% | 8,559 | +1.5% | 0.08% | +1.4% |
| Q1 2022 | $2,473,000 | +1.7% | 8,429 | +14.0% | 0.07% | +8.8% |
| Q4 2021 | $2,432,000 | -6.6% | 7,391 | -13.6% | 0.07% | -12.8% |
| Q3 2021 | $2,605,000 | +14.8% | 8,556 | +1.2% | 0.08% | +14.7% |
| Q2 2021 | $2,269,000 | +26.5% | 8,454 | +6.1% | 0.07% | +19.3% |
| Q1 2021 | $1,793,000 | +6.9% | 7,965 | +5.5% | 0.06% | 0.0% |
| Q4 2020 | $1,677,000 | +8.2% | 7,547 | +4.8% | 0.06% | -6.6% |
| Q3 2020 | $1,550,000 | +11.4% | 7,200 | -8.5% | 0.06% | 0.0% |
| Q2 2020 | $1,391,000 | +31.1% | 7,866 | +2.6% | 0.06% | -3.2% |
| Q1 2020 | $1,061,000 | -23.5% | 7,663 | -15.2% | 0.06% | +6.8% |
| Q4 2019 | $1,387,000 | +16.2% | 9,039 | +9.4% | 0.06% | +3.5% |
| Q3 2019 | $1,194,000 | +1.6% | 8,264 | +0.5% | 0.06% | -6.6% |
| Q2 2019 | $1,175,000 | +29.3% | 8,224 | +19.4% | 0.06% | +17.3% |
| Q1 2019 | $909,000 | +24.9% | 6,886 | -2.5% | 0.05% | -1.9% |
| Q4 2018 | $728,000 | -6.3% | 7,062 | -1.2% | 0.05% | +15.2% |
| Q3 2018 | $777,000 | +15.8% | 7,149 | +5.1% | 0.05% | +2.2% |
| Q2 2018 | $671,000 | +5.7% | 6,799 | +4.9% | 0.04% | -2.2% |
| Q1 2018 | $635,000 | +25.2% | 6,480 | +18.6% | 0.05% | +17.9% |
| Q4 2017 | $507,000 | +10.5% | 5,463 | +2.1% | 0.04% | +2.6% |
| Q3 2017 | $459,000 | +10.3% | 5,350 | +8.6% | 0.04% | -2.6% |
| Q2 2017 | $416,000 | +22.0% | 4,928 | +23.5% | 0.04% | +18.2% |
| Q1 2017 | $341,000 | +29.2% | 3,991 | +17.8% | 0.03% | +13.8% |
| Q4 2016 | $264,000 | +7.8% | 3,389 | +8.4% | 0.03% | 0.0% |
| Q3 2016 | $245,000 | -19.4% | 3,127 | +4.1% | 0.03% | -27.5% |
| Q2 2016 | $304,000 | +34.5% | 3,005 | +26.0% | 0.04% | +29.0% |
| Q1 2016 | $226,000 | – | 2,385 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |